In addition to reducing basal TfR1 and elevating Fpn in activated CF MDMs, we observed that ex vivo pretreatment with modulators robustly impacted CF MDM iron sequestration and biofilm formation of DH1137 (Figs. 3b, 4c). This evidence concerns the gene SLC40A1 and cystic fibrosis.